No Induction Versus Anti-IL2R Induction Therapy in Simultaneous Kidney Pancreas Transplantation: A Comparative Analysis (original) (raw)

LIMITED BENEFITS OF INDUCTION WITH MONOCLONAL ANTIBODY TO INTERLEUKIN-2 RECEPTOR IN COMBINATION WITH TACROLIMUS, MYCOPHENOLATE MOFETIL, AND STEROIDS IN SIMULTANEOUS KIDNEY-PANCREAS TRANSPLANTATION

Hani Grewal, A.osama Gaber

Transplantation, 2000

View PDFchevron_right

Initial clinical experience with interleukin-2 receptor antagonist induction in combination with tacrolimus, mycophenolate mofetil and steroids in simultaneous kidney-pancreas transplantation

Hani Grewal, A.osama Gaber

Transplant International, 2001

View PDFchevron_right

Prospective, Randomized, Multi-Center Trial of Antibody Induction Therapy in Simultaneous Pancreas-Kidney Transplantation

Waldo Concepcion, George Burke

American Journal of Transplantation, 2003

View PDFchevron_right

Immunosuppression in pancreas transplantation: progress, problems and perspective

Nicole Turgeon

Transplant Immunology, 1998

View PDFchevron_right

Technical and immunologic progress in simultaneous pancreas-kidney transplantation

Michael Abecassis

Surgery, 2002

View PDFchevron_right

Immunosuppressive Drugs After Simultaneous Pancreas-Kidney Transplantation

Jean-Paul Squifflet

Transplantation Proceedings, 2005

View PDFchevron_right

Impact of Immunosuppression on Improvement of Results in Clinical Pancreas Transplantation Clinical Pancreas Transplantation

Marco Melandri

Diabetes, 1989

View PDFchevron_right

Immunosuppression in pancreas transplantation: the Euro SPK trials and beyond

Jean-Paul Squifflet

Acta chirurgica Belgica

View PDFchevron_right

Improved Solitary Pancreas Transplant Graft Survival in the Modern Immunosuppressive Era

Hans Sollinger

Transplantation, 1999

View PDFchevron_right

The long-term survival of simultaneous pancreas and kidney transplant with basiliximab induction therapy

Anil Paramesh

Clinical Transplantation, 2007

View PDFchevron_right

Quadruple drug induction therapy in combined renal and pancreas transplantation

Manfred Stangl

1990

View PDFchevron_right

Pretransplant immunosuppression for pancreas transplants alone in nonuremic diabetic recipients

Angelika C Gruessner

Transplantation Proceedings, 2001

View PDFchevron_right

Long-Term Results of Pancreas Transplantation Under Tacrolimus IMMUNOSUPPRESSION1

John J Fung

Transplantation, 1999

View PDFchevron_right

Good Results with Individually Adapted Long-Term Immunosuppression Following Alemtuzumab Versus ATG Induction Therapy in Combined Kidney-Pancreas Transplantation: A Single-Center Report

Hannes Neuwirt

Annals of Transplantation, 2019

View PDFchevron_right

The metabolic and toxicological considerations for immunosuppressive drugs used during pancreas transplantation

Shekoufeh Nikfar

Expert Opinion on Drug Metabolism & Toxicology, 2012

View PDFchevron_right

Calcineurin Inhibitor- and Steroid-Free Immunosuppression in Pancreas-Kidney and Solitary Pancreas Transplantation

Angelika Gruessner

Transplantation, 2005

View PDFchevron_right

The role of anti–IL-2 receptor in high-risk kidney transplant patients

S. Jirasiritham

Transplantation Proceedings, 2004

View PDFchevron_right

A Retrospective Monocenter Review of Simultaneous Pancreas-Kidney Transplantation

Jean-Paul Squifflet

Transplantation Proceedings, 2009

View PDFchevron_right

Randomized comparison of triple therapy and antithymocyte globulin induction treatment after simultaneous pancreas-kidney transplantation

Jean-paul P Soulillou

Kidney International, 1998

View PDFchevron_right

Use of tacrolimus and mycophenolate mofetil as induction and maintenance in simultaneous pancreas-kidney transplantation

Buscemi Giuseppe

Transplant International, 2000

View PDFchevron_right

Pancreas-kidney transplantation: clinical, metabolic and immunological outcomes

A. Castro-henriques

portuguese journal of nephrology and hypertension, 2016

View PDFchevron_right

Long-Term Efficacy of Induction Therapy With Anti–Interleukin-2 Receptor Antibodies or Thymoglobulin Compared With No Induction Therapy in Renal Transplantation

K. Chavin, Charles Bratton

Transplantation Proceedings, 2008

View PDFchevron_right

An Evidence-Based Analysis of Simultaneous Pancreas-Kidney and Pancreas Transplantation Alone

Pierre-alain Clavien

American Journal of Transplantation, 2005

View PDFchevron_right

Improving results in solitary pancreas transplantation with portal-enteric drainage, thymoglobin induction, and tacrolimus/mycophenolate mofetil-based immunosuppression

Hosein Shokouh-amiri

Transplant International, 2003

View PDFchevron_right

Immunosuppression in pancreas transplantation: mycophenolate mofetil versus sirolimus

Santo Vitola, Fabian Pires, Valter Garcia, Elizete Keitel, Ana Santos

Transplantation Proceedings, 2004

View PDFchevron_right

Alemtuzumab Induction and Steroid-Free Maintenance Immunosuppression in Pancreas Transplantation

Anand Deb

American Journal of Transplantation, 2008

View PDFchevron_right

Low rejection rate with high-dose ATG bolus therapy in simultaneous pancreas and kidney transplantation

Tereza Havrdova

Transplantation Proceedings

View PDFchevron_right

Antibody-Mediated Rejection of the Kidney after Simultaneous Pancreas-Kidney Transplantation

Julio Pascual

Journal of the American Society of Nephrology, 2008

View PDFchevron_right